Global Vitamin K2 Market Research Report Forecast to 2023


SKU: 190728 Category: Tag:


Vitamin K2 Market Research Report: by Product Type (MK-7, MK-4, Others), by Source (Natural, Synthetic), by Form (Oil, Powder, Others), by Application (Nutraceutical & Food, Pharmaceutical), and Region – Global Forecast till 2023
Market analysis

Vitamin K2, otherwise called menaquinones, are a compound group known for averting cardiovascular maladies and bone illnesses. The nutrient is in charge of guaranteeing calcium consumed by the bone network and avert its disposition in the arteries. The global vitamin K2 market is assessed to contact a valuation of USD 228.27 million by 2023, according to the most recent discoveries of Market Research Future (MRFR). It is anticipated to enlist 5.80% CAGR over the gauge time frame (2018-2025). It was recently esteemed at USD 45 million of every 2017. It is principally determined by the ascent in nutrient inadequacy cases. Increment in wellbeing awareness combined with the tendency of customers towards dietary enhancements can drive the global vitamin K2 market development. Rising instances of osteoporosis which can quicken maturing of tissues is another factor which can decidedly affect the market. However, exacting guidelines by government bureaucratic organizations for endorsement of supplements can go about as a development obstacle.

Market segmentation

The global vitamin K2 market is bifurcated on the basis of source, product type, form, application and regional demand. On the basis of its product type, the market is divided into MK-4, MK-7, and others. Based on its sources, the market is segmented into synthetic and nautral. On the basis of its form, the market is bifurcated into powder and oil. Based on its applications, the market include pharmaceutical and nutraceutical & food.

Regional analysis

Geographically, the global vitamin K2 market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Major players

DSM (The Netherlands), Danisco A/S (U.S.), Geneferm Biotechnology Co. Ltd. (Taiwan), Frutarom (Israel), and Kyowa Hakko Bio Co. Ltd. (Japan), Kappa Bioscience (Norway), NattoPharma (Norway), Gnosis SpA (Italy), Viridis BioPharma (India), Seebio Biotech (China), among others are some of the key players in the global vitamin K2 market.

Table of Contents

Table of Contents:

1 Report Prologue
2 Executive Summary
3 Market Introduction
3.1 Definition
3.2 Scope of the Study
3.3 List of Assumptions
3.4 Market Structure
4 Research Methodology
4.1 Research Process
4.2 Primary Research
4.3 Secondary Research
4.4 Market Size Estimation
4.5 Forecast Model
4.6 Introduction
4.7 Drivers
4.7.1 Increasing patient pool suffering from vitamin deficiency
4.7.2 Increasing demand for nutraceutical products containing vitamin K2
4.7.3 Increasing cases of osteoporosis
4.8 Restraints
4.8.1 Stringent regulations for nutraceuticals adversely affect the market
4.9 Opportunity
4.9.1 Multifunctional ingredients
5 Market Factor Analysis
5.1 Porter’s Five Forces Model
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Rivalry
5.2 Supply Chain Analysis
5.2.1 Raw Material Planning & Procurement Fermentation Filtration Extraction Filtration Purification
5.2.2 Packaging
5.2.3 Transportation
5.2.4 Distribution Marketing & Sales
5.2.5 Post-sales Services
6 Global Vitamin K2 Market, by Product Type
6.1 Introduction
6.2 MK-7
6.3 MK-4
7 Global Vitamin K2 Market, by Source
7.1 Introduction
7.2 Natural
7.3 Synthetic
8 Global Vitamin K2 Market, by Form
8.1 Introduction
8.2 Powder
8.3 Oil
9 Global Vitamin K2 Market, by Application
9.1 Introduction
9.2 Nutraceutical and Food
9.3 Pharmaceutical
10 Global Vitamin K2 Market, by Region
10.1 Introduction
10.2 Americas
10.2.1 North America US Canada
10.2.2 Latin America
10.3 Europe
10.3.1 Western Europe UK Germany France Italy Spain Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia-Pacific
10.4.1 Australia
10.4.2 Japan
10.4.3 China
10.4.4 India
10.4.5 South Korea
10.4.6 Rest of Asia-Pacific
10.5 Middle East & Africa
10.5.1 Middle East
10.5.2 Africa
11 Competitive Landscape
11.1 Introduction
11.2 Company Market Share Analysis
12 Company Profiles
12.1 Kappa Bioscience
12.1.1 Company Overview
12.1.2 Financial Overview
12.1.3 Products/Services Offered
12.1.4 Key Developments
12.1.5 SWOT Analysis
12.1.6 Key Strategies
12.2 NattoPharma
12.2.1 Company Overview
12.2.2 Financial Overview
12.2.3 Products/Services Offered
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.2.6 Key Strategies
12.3 Gnosis SpA
12.3.1 Company Overview
12.3.2 Financial Overview
12.3.3 Products/Services Offered
12.3.4 Key Developments
12.3.5 SWOT Analysis
12.3.6 Key Strategies
12.4 Viridis BioPharma
12.4.1 Company Overview
12.4.2 Financial Overview
12.4.3 Products/Services Offered
12.4.4 Key Developments
12.4.5 SWOT Analysis
12.4.6 Key Strategies
12.5 Seebio Biotech
12.5.1 Company Overview
12.5.2 Financial Overview
12.5.3 Products/Services Offered
12.5.4 Key Developments
12.5.5 SWOT Analysis
12.5.6 Key Strategies
12.6 DSM
12.6.1 Company Overview
12.6.2 Financial Overview
12.6.3 Products/Services Offered
12.6.4 Key Developments
12.6.5 SWOT Analysis
12.6.6 Key Strategies
12.7 Danisco A/S
12.7.1 Company Overview
12.7.2 Financial Overview
12.7.3 Products/Services Offered
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.7.6 Key Strategies
12.8 Geneferm Biotechnology Co. Ltd
12.8.1 Company Overview
12.8.2 Financial Overview
12.8.3 Products/Services Offered
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.8.6 Key Strategies
12.9 Frutarom
12.9.1 Company Overview
12.9.2 Financial Overview
12.9.3 Products/Services Offered
12.9.4 Key Developments
12.9.5 SWOT Analysis
12.9.6 Key Strategies
12.1 Kyowa Hakko Bio Co. Ltd
12.10.1 Company Overview
12.10.2 Financial Overview
12.10.3 Products/Services Offered
12.10.4 Key Developments
12.10.5 SWOT Analysis
12.10.6 Key Strategies
13 Appendix
13.1 Discussion Blueprint

Additional information


Geography Covered

Date Published